![]() |
![]() |
FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA
![]()
Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857
This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.
![]() |
April 11, 2005 |
![]() |
|||
|---|---|---|---|---|---|
FDA Official and Title |
Date and Site |
Other FDA Participants |
Non-FDA Participants |
Subject |
|
| Gerald F. Masoudi, Acting Chief Counsel | 4/4/05 FDA Rockville | Jeff Shuren, OP and William McConagha, OCC | Michael E. Peppel, Dr. Krishna S. Vishnupad, NeuroSci, Inc.; John Serio, Brown, Rudnick, Berlack, Israels | Comb. Drug/Diet Supp Products | |
| Gerald F. Masoudi, Acting Chief Counsel | 4/7/05 FDLI/Washington, D.C. | None | None | Spoke at Annual FDLI Meeting | |
| Marsha B. Henderson, MCRP, Acting Assistant Commissioner for Women's Health Office of Women's Health (OWH) | 4/7/05 FDA Rockville | Margaret Miller, PhD, DABT, RN, Scientific Programs Manager, OWH and Susana Perry, MS, BS, Health Programs Coordinator, OWH | Phyllis Greenberger, MSW, President & CEO, Society for Women's Health Research (SWHR); Sherry marts, PhD, Vice President, Scientific Affairs, SWHR; Martha Nolan, JD, Vice President, Public Policy, SWHR; and L. Jo Parrish, MA, MBA, Vice President, Institutional Advancement, SWHR | To discuss collaborations with OWH regarding health education campaigns | |
| Jesse L. Goodman, MD, MPH, Director, CBER | 4/6-8/05 Washington, DC | Unknown | Conference attendees and Food and Drug Law Institute (FDLI) Annual Meeting | CBER Update on various biologics issues | |
| Jesse L. Goodman, MD, MPH, Director, CBER | 4/4-5/05 Washington, DC | Unknown; Staff from CBER Office of Vaccines Research and Review | Conference attendees; LaMontagne Memorial Symposium on Pandemic Influenza Research at National Academy of Sciences in conjunction with IOM and WHO | Talk entitled "Meeting the Challenge of pandemic Vaccine Preparedness: An FDA Perspective" | |
![]()